Plain-English translation of NCT02748408 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term safety study of the SMS femoral stem, a component used in hip replacement surgery. Researchers are following patients who receive this implant to see how well it works and whether any problems develop over 10 years. The study involves regular check-ups and imaging to monitor the health of the replaced hip.
After a medical device is approved and used in patients, companies are required to monitor its real-world performance to ensure it is safe and effective over time. This study collects that important safety and performance data.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive the SMS femoral stem as part of your hip replacement surgery. After surgery, you will attend regular follow-up appointments over 10 years—typically at 6 weeks, 3 months, 1 year, and then yearly—where your doctor will examine your hip and may take X-rays or other imaging to make sure the implant is working well. Your participation helps ensure this device remains safe and effective for future patients.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Austria
Italy
Switzerland
United Kingdom
Sponsor
Medacta International SA
Enrollment target
~550 participants
Started
July 2015
Primary completion
July 2032
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mara Colombo, Eng
Medacta International SA
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.